Neuralink, Musk's Brain-Computer Interface Company, Launches First Human Trials Recruiting Patients with Quadriplegia and ALS

Prices for Brain-Computer Interface Medical Services Released in Hubei Province

Hubei province in China has released the nation's first price list for brain-computer interface medical services, starting from 6552 yuan.

Chinese Scientists Release World's First Micrometer-Scale Brain-Computer Interface 3D Atlas, Enhancing Surgical Safety

Researchers in China have unveiled the world's first three-dimensional atlas of a brain-computer interface at the micrometer scale. This groundbreaking achievement significantly improves the safety and precision of brain surgery involving BCIs.

Science Fiction Becomes Reality! Yale University Releases MindLLM: AI Translates fMRI Brain Signals into Text!

Yale University researchers have developed MindLLM, an AI model capable of translating fMRI brain signals directly into text. This groundbreaking technology bridges the gap between brain activity and human language, opening new possibilities for communication and understanding the human brain.

80% Accuracy! Meta Develops Non-Invasive Brain-Computer Interface That Allows Typing with Thought

Social media giant Meta recently announced that they have developed a new device capable of reading brain neural signals to enable text input. This research achievement is detailed by Meta's scientists in two studies, utilizing advanced brain imaging technology and deep learning AI models to successfully decode the brain signals of individuals while they type, even reconstructing complete sentences. Specifically, this technology relies on a scanning device known as magnetoencephalography (MEG), which can capture the faint magnetic signals emitted by the brain.

China's Brain-Computer Interface Sector Sets Record! Ladder Medical Completes $350 Million Series B Financing

The AI Drug Revolution is Coming: Google DeepMind CEO Says New Drug Clinical Trials May Begin in 2025!

At the recent World Economic Forum in Davos, Google DeepMind's CEO Demis Hassabis stated that the first drugs designed with the help of artificial intelligence could begin clinical trials by 2025. Hassabis also heads Isomorphic Labs, a drug research company under DeepMind. He stated, "Our plan is to have some AI-designed drugs enter clinical trials by the end of this year."

Google Founder Demis Hassabis's Company Plans to Start AI-Driven Drug Clinical Trials by Year-End

Recently, Demis Hassabis, one of the founders of Google, revealed in an interview that his company Isomorphic Labs plans to begin a clinical trial for a drug developed using artificial intelligence (AI) by the end of the year. This news has drawn significant attention, particularly regarding its potential applications in oncology, cardiovascular diseases, and neurodegenerative disorders. Image credit: Image generated by AI, image licensed from Midjourney Isomorphic.

New AI Wearable Device Omi: Enhance Your Work Efficiency with Brain-Computer Interface

Precision Raises $102 Million: Brain-Computer Interface May Transform Treatment of Neurological Disorders

Breakthrough Brain-Computer Interface: Shanghai's First Paralyzed Patient Successfully Controls Drinking with Brain Signals

According to the Shanghai Municipal Science and Technology Commission, Shanghai has once again set a new record in medical technology. On November 6, Huashan Hospital's neurosurgery department successfully completed a pioneering clinical implant trial of a brain-computer interface, bringing hope to paralyzed patients for regaining autonomy in their lives. This groundbreaking technology was jointly developed by Borye Medical Technology and Professor Hongbo's team from Tsinghua University. Patient Xiao Dong, after being paralyzed for four years, successfully collected neural signals from the sensory-motor area of the brain using a brain-computer interface device the size of a coin. Unlike traditional invasive brain-computer interfaces, this system employs a wireless minimally invasive design.